Ghaziabad News: A major interstate racket has been exposed by Delhi Police. Police located a fake medicine manufacturing unit and seized counterfeit drugs and raw material worth over ₹2.3 crore.
The racket was alleged involved in the repackaging, manufacturing and nationwide sale of spurious Schedule-H medicines.
Two men – Shree Ram alias Vishal Gupta of northeast Delhi’s Sabhapur and Gaurav Bhagat, a resident of Uttar Pradesh’s Ghaziabad – were arrested by the police in this case.
Ghaziabad News-The Complete Incident
In a statement, Deputy Commissioner of Police (Crime Branch) Aditya Gautam said the crackdown was carried out by the Crime Branch. Gautam added the two accused were engaged in selling and producing counterfeit versions of popular prescription ointments, including Clop-G and Betnovate-C that are widely used drugs to treat allergies, skin infections and sports-related injuries.
The office also remarked that the spurious medicines were illegally being sold as genuine, branded products that pose a severe risk to public health.
The Crime Branch acting on inputs first conducted a raid at Teliwara, Sadar Bazar, which is one of India’s largest wholesale pharmaceutical and cosmetic markets.
It was further reported that a significant quantity of counterfeit Schedule-H ointments was recovered during the raid. Thereafter, a team visited a manufacturing unit operating from Meerpur Hindu village in the Loni area of Ghaziabad after subsequent technical analysis and follow-up intelligence. The DCP said the team recovered huge quantities of raw chemicals, counterfeit medicines and empty tubes that were bearing forged brand labels and machinery used for mixing, filling and sealing ointments.
The DCP also said the duo were operating without a valid license to manufacture, store or sell pharmaceutical products. It was also said the medicines were counterfeit and neither manufactured nor supplied by their companies.
Delhi Police remarked an FIR against the two accused was registered registered at the Crime Branch police station on December 12 under various sections of the BNS and provisions of the Drugs and Cosmetics Act.
